Tomofumi Miura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tomofumi Miura has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Cipriani
University of Oxford
3 shared publications - Georgia Salanti
Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
3 shared publications - Hisashi Noma
The Graduate Institute for Advanced Studies , The Graduate University for Advanced Studies , Tokyo , Japan
3 shared publications Keisuke Motomura
Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan
3 shared publications- Toshiaki A. Furukawa
Kyoto University Graduate School of Medicine/School of Public Health
3 shared publications Hiroshi Mitsuyasu
Department of Neuropsychiatry Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
2 shared publications
Latest Publications
- 13 February 2017
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 71 (6) , 373-382
Neurocognitive profile of euthymic Japanese patients with bipolar disorder
Aim: Neurocognitive impairment is one of the core symptoms of bipolar disorder (BD). The MATRICS Cognitive Consensus Battery (MCCB) is a potential consensus assessment tool to evaluate cognitive function in patients with BD. Here, we report on cognitive deficits evaluated using the MCCB Japanese version (MCCB‐J) in euthymic Japanese patients with BD, and compare them with scores in previous studies.Methods: We compared neurocognitive function in 25 patients with euthymic BD and 53 healthy controls (HC). Additionally, we searched all available databases for studies that have evaluated cognitive function in BD using the MCCB, and conducted a meta‐analysis.Results: Canonical discriminant analysis revealed significant differences in MCCB‐J domain scores between BD and HC. Patients with BD performed significantly worse on visual learning, social cognition, speed of processing, and MCCB composite scores. Our meta‐analysis revealed that patients with BD performed worse than HC, as reflected by MCCB composite scores and scores on all seven cognitive domains. However, there are differences in the cognitive deficits identified in previous studies compared with our participants, particularly social cognition.Conclusion: As reported in previous studies, neurocognitive deficits were observed in Japanese euthymic BD patients assessed using the MCCB‐J. Further study is needed to clarify whether differences in social cognition between this study and previous studies are a result of coping mechanisms for social settings in Japanese populations.
- 13 February 2017
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 71 (6) , 373-382
Neurocognitive profile of euthymic Japanese patients with bipolar disorder
Aim: Neurocognitive impairment is one of the core symptoms of bipolar disorder (BD). The MATRICS Cognitive Consensus Battery (MCCB) is a potential consensus assessment tool to evaluate cognitive function in patients with BD. Here, we report on cognitive deficits evaluated using the MCCB Japanese version (MCCB‐J) in euthymic Japanese patients with BD, and compare them with scores in previous studies.Methods: We compared neurocognitive function in 25 patients with euthymic BD and 53 healthy controls (HC). Additionally, we searched all available databases for studies that have evaluated cognitive function in BD using the MCCB, and conducted a meta‐analysis.Results: Canonical discriminant analysis revealed significant differences in MCCB‐J domain scores between BD and HC. Patients with BD performed significantly worse on visual learning, social cognition, speed of processing, and MCCB composite scores. Our meta‐analysis revealed that patients with BD performed worse than HC, as reflected by MCCB composite scores and scores on all seven cognitive domains. However, there are differences in the cognitive deficits identified in previous studies compared with our participants, particularly social cognition.Conclusion: As reported in previous studies, neurocognitive deficits were observed in Japanese euthymic BD patients assessed using the MCCB‐J. Further study is needed to clarify whether differences in social cognition between this study and previous studies are a result of coping mechanisms for social settings in Japanese populations.
- Open Access
- 14 April 2016
- Published by Springer Nature in BMC Research Notes
- Vol. 9 (1) , 218
Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review
Limitations in the primary studies constitute one important factor to be considered in the grading of recommendations assessment, development, and evaluation (GRADE) system of rating quality of evidence. However, in the network meta-analysis (NMA), such evaluation poses a special challenge because each network estimate receives different amounts of contributions from various studies via direct as well as indirect routes and because some biases have directions whose repercussion in the network can be complicated. In this report we use the NMA of maintenance pharmacotherapy of bipolar disorder (17 interventions, 33 studies) and demonstrate how to quantitatively evaluate the impact of study limitations using netweight, a STATA command for NMA. For each network estimate, the percentage of contributions from direct comparisons at high, moderate or low risk of bias were quantified, respectively. This method has proven flexible enough to accommodate complex biases with direction, such as the one due to the enrichment design seen in some trials of bipolar maintenance pharmacotherapy. Using netweight, therefore, we can evaluate in a transparent and quantitative manner how study limitations of individual studies in the NMA impact on the quality of evidence of each network estimate, even when such limitations have clear directions.
- 14 April 2016
- Published by Springer Nature in BMC Research Notes
- Vol. 9 (1) , 218
Open AccessUsing the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review
Limitations in the primary studies constitute one important factor to be considered in the grading of recommendations assessment, development, and evaluation (GRADE) system of rating quality of evidence. However, in the network meta-analysis (NMA), such evaluation poses a special challenge because each network estimate receives different amounts of contributions from various studies via direct as well as indirect routes and because some biases have directions whose repercussion in the network can be complicated. In this report we use the NMA of maintenance pharmacotherapy of bipolar disorder (17 interventions, 33 studies) and demonstrate how to quantitatively evaluate the impact of study limitations using netweight, a STATA command for NMA. For each network estimate, the percentage of contributions from direct comparisons at high, moderate or low risk of bias were quantified, respectively. This method has proven flexible enough to accommodate complex biases with direction, such as the one due to the enrichment design seen in some trials of bipolar maintenance pharmacotherapy. Using netweight, therefore, we can evaluate in a transparent and quantitative manner how study limitations of individual studies in the NMA impact on the quality of evidence of each network estimate, even when such limitations have clear directions.
- 1 November 2014
- Published by Elsevier in The Lancet Psychiatry
- Vol. 1 (6) , 418-419
Bipolar treatment efficacy – Authors' reply
- 1 November 2014
- Published by Elsevier in The Lancet Psychiatry
- Vol. 1 (6) , 418-419
Bipolar treatment efficacy – Authors' reply
- 1 October 2014
- Published by Elsevier in The Lancet Psychiatry
- Vol. 1 (5) , 351-359
Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis
- 1 October 2014
- Published by Elsevier in The Lancet Psychiatry
- Vol. 1 (5) , 351-359
Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis
- 1 January 2014
- Vol. 116 (9) , 735-45
[Adverse drug reactions of psychotropic agents: adverse drug reactions and safety monitoring of psychotropic agents].
Pharmacological treatments of psychiatric illness have been developed and many psychotropic drugs are now on the market. The body of safety information regarding psychotropic agents is so large that it is difficult for clinicians to consider all the details of possible adverse drug reactions(ADRs) in daily clinical practice. Although it is impossible to predict and prevent all occurrences of ADRs, many of them may be preventable. In this context, there is a strong need for compact manuals of diagnosis and treatment for ADRs arising from psychotropic agents that are likely to be used in daily practice. Under the auspices of the Japanese Society of Psychiatry and Neurology, a task force was convened to answer this need. This review focuses on the general considerations of ADRs with psychotropic agents, based on discussions of the task force. We also discuss the guidelines for drug safety monitoring, targeted towards specific psychiatric disorders or patients taking specific classes of drugs. Finally, we introduce the Adverse Drug Reactions Relief System in Japan.
- 1 January 2014
- Vol. 116 (9) , 735-45
[Adverse drug reactions of psychotropic agents: adverse drug reactions and safety monitoring of psychotropic agents].
Pharmacological treatments of psychiatric illness have been developed and many psychotropic drugs are now on the market. The body of safety information regarding psychotropic agents is so large that it is difficult for clinicians to consider all the details of possible adverse drug reactions(ADRs) in daily clinical practice. Although it is impossible to predict and prevent all occurrences of ADRs, many of them may be preventable. In this context, there is a strong need for compact manuals of diagnosis and treatment for ADRs arising from psychotropic agents that are likely to be used in daily practice. Under the auspices of the Japanese Society of Psychiatry and Neurology, a task force was convened to answer this need. This review focuses on the general considerations of ADRs with psychotropic agents, based on discussions of the task force. We also discuss the guidelines for drug safety monitoring, targeted towards specific psychiatric disorders or patients taking specific classes of drugs. Finally, we introduce the Adverse Drug Reactions Relief System in Japan.